Current Market Dynamics, Future Market Opportunities And Lifecycle Strategies For Drug Delivery Technologies Industry

DUBLIN, Ireland --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/f02446/drug_delivery_tech) has announced the addition of the "Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies" report to their offering.

The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit from patent expiry by providing their reformulation services to pharmaceutical companies, but also by producing their own versions of branded products with improved delivery mechanisms. Thus, post-patent expiry sales can be switched from the ethical manufacturer to the drug delivery sector.

Drug Delivery Technologies: Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies is an up-to-date guide that assesses the current state of the drug delivery industry and its application to both the pharmaceutical and biotech industries. While the sector is still dominated by oral technologies, drug delivery systems have expanded to include more novel devices such as needleless injectables, PEGylation platforms and microelectromechanical devices. These technological advances extend the duration of a drug's action, increase delivery to target sites, reduce delivery to unwanted sites, and maximize drug absorption.

The expanding market for biotechnology and gene-based products, which by their very nature are difficult to administer, represents an emerging opportunity for drug delivery technologies. These technologies are first expected to come to market as reformulations of existing macromolecular therapies, such as insulin. This report analyzes the markets for oral, inhalable, injectable, transmucosal, transdermal and niche drug delivery technologies as they apply to both biotech and traditional pharmacological compounds.

Key Features of This Report

• A thorough overview of both marketed and emerging drug delivery technologies set to impact the global pharmaceutical market
• Analysis of the opportunities and threats to the global drug delivery industry
• Profiles of drug delivery companies along with key financial figures and technology/product portfolios
• Market analysis and outlook for the leading drug delivery technologies, including oral, injectable, inhalable, transdermal,transmucosal and niche technologies
• Profiles of key emerging drug delivery technologies and profiles of leading companies, by type of technology
• An overview of the global drug delivery market, with sales for key drug delivery categories and key products within each one of them
• Identification of key areas associated with the successful development of new drug delivery systems
• Critical assessment of market trends, forecasts and problems in the global drug delivery market
• Explanations of key technologies and mechanism of action of new drug delivery technologies and products utilizing them
• Thorough descriptions of important areas of research and development in the drug delivery market

What questions does this report answer?

• What are the key trends in the field of drug delivery as a whole?
• What are the major issues involved in the research and development of more effective drug delivery systems?
• What types of drug delivery technologies are currently in research and development in each of the main drug delivery categories?
• What is the value of new drug delivery technologies in terms of a product's lifecycle management?
• Which new drug delivery systems are likely to provide the best commercial opportunities for their manufacturers?

Highlights of this report

• Discussion and analysis of the problems associated with the use of traditional drug delivery technologies: lack of patient compliance,considerable adverse effects, inferior clinical efficacy due to the lack of targeted delivery
• Identification of the challenges to the development of better, more efficacious drug delivery technologies, with fewer side effects
• Focused analysis of the global market for major drug delivery technologies: oral, inhalable, injectable, transdermal, transmucosal and topical, as well as niche technologies, such as gene delivery
• Identification of the major products in research and development utilizing new technologies
• Highlights of the drug delivery systems that are most likely to impact the global market

Reasons to purchase

• Provides a comprehensive description of the current state of affairs in the global drug delivery field
• Provides a comprehensive description of the main drug delivery technologies and key products within each of the categories
• Asesses key products and technologies in clinical development
• Provides a guide to optimizing drug reformulation processes
• Provides a guide to business models of drug delivery companies
• Identifies key issues facing drug delivery and pharmaceutical companies in the development of new drug delivery systems

Key Topics Covered:

• Introducing The Field Of Drug Delivery
• An Overview Of Drug Delivery Technologies
• Overview Of Global Drug Delivery Market
• Drug Delivery Market Analysis
• Emerging Drug Delivery Technologies: Oral Drug Delivery
• Emerging Drug Delivery Technologies: Inhalable Drug Delivery
• Emerging Drug Delivery Technologies: Injectable Drug Delivery
• Emerging Drug Delivery Technologies: Transmucosal Drug Delivery
• Emerging Drug Delivery Technologies: Transdermal Drug Delivery
• Emerging Drug Delivery Technologies: Niche Drug Delivery Technologies
• Key Drug Delivery Company Profiles

Companies Mentioned:

• 3m Pharmaceuticals
• Alkermes
• Altea Therapeutics
• Alza (Johnson & Johnson)
• Aradigm
• Bioject
• Biovail
• Cardinal Health
• Cima Labs (Cephalon)
• Connetics (Stiefel Laboratories Inc)
• Cydex Pharmaceuticals
• Delsite Biotechnologies (Carrington Laboratories)
• Depomed
• Dor Biopharma
• Durect
• Emisphere
• Enzon
• Enzon
• Ethypharm
• Eurand
• Generex
• Inovio (Formerly Genetronics)
• Ivax (Part Of Teva)
• Macrochem
• Macromed (Now Protherics)
• Nastech (Now Mdrna)
• Nektar
• Nexmed
• Noven
• Penwest
• Pherin Pharmaceuticals
• Psivida
• Qlt
• Skyepharma
• Watson Pharmaceuticals
• Zogenix

For more information visit http://www.researchandmarkets.com/research/f02446/drug_delivery_tech

SOURCE: Research and Markets